Requests that the FDA determine whether MYSOLINE primidone Suspension 250 mg/5 mL approved under New Drug Application NDA number 010401 held by Nuro Pharma LLC has been voluntarily withdrawn for reasons of safety or effectiveness
🏛 Food and Drug Administration (FDA)FDA-2022-P-3118
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.